Principal Investigator
Cynthia Levy
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20240043
Clinical Trial Summary
A Phase 2, Randomized, Placebo-controlled, Parallel Group, Multicenter 12-week Study with a 52-week Extension to Evaluate the Efficacy and Safety of Two Doses of K-808 (Pemafibrate) in Subjects with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid and/or
Obeticholic Acid Treatment
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
PBC (Primary Biliary Cholangitis)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu